Want to get this daily news briefing by email? Here’s the sign-up.
WHAT WE’RE WATCHING
DOSE OF MEDICINE – Big Law has an outsized part to play in the development of the COVID-19 vaccine, Patrick Smith and Dan Packel report. In the race to create coronavirus vaccines, Arnold & Porter Kaye Scholer and Hogan Lovells are two of the firms guiding companies through regulatory and contractual obstacle courses. An attorney from Arnold & Porter says that its relationships within the life sciences and healthcare industries might be one reason the firm won the business of pharma companies such as AstraZeneca, which has attracted $1.2 billion in federal grants to team up with Oxford University on a vaccine.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
